We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT PR Newswire SUNNYVALE, Calif., Sept...
Everyone is looking for sustainable and clean products. And shares of this firm, which develops and produces precision fermented functional ingredients for the health and wellness, food and To...
WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC. Canada NewsWire SUNNYVALE, Calif., Sept. 5, 2024 The agreement with Kalsec anticipates milestone payments for finalizing...
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire SUNNYVALE, Calif., Aug. 12, 2024 Company reports record revenue of $1.0 million, an...
WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY PR Newswire SUNNYVALE, Calif., Aug. 7, 2024 After a...
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS Canada NewsWire SUNNYVALE, Calif., July 26, 2024 SUNNYVALE, Calif., July 26, 2024 /CNW/ - Willow Biosciences Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -10 | 0.1 | 0.1 | 0.09 | 18025 | 0.09520326 | CS |
4 | -0.01 | -10 | 0.1 | 0.105 | 0.09 | 33229 | 0.10023742 | CS |
12 | -0.005 | -5.26315789474 | 0.095 | 0.105 | 0.08 | 67290 | 0.09429619 | CS |
26 | 0 | 0 | 0.09 | 0.145 | 0.075 | 77076 | 0.10177397 | CS |
52 | 0 | 0 | 0.09 | 0.15 | 0.065 | 77226 | 0.10089148 | CS |
156 | -0.45 | -83.3333333333 | 0.54 | 0.58 | 0.06 | 98601 | 0.17435942 | CS |
260 | -0.51 | -85 | 0.6 | 2.24 | 0.06 | 151850 | 0.63071882 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions